Filing Details

Accession Number:
0001104659-21-035159
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-11 21:09:16
Reporting Period:
2021-03-09
Accepted Time:
2021-03-11 21:09:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124524 Cryoport Inc. CYRX Pharmaceutical Preparations (2834) 880313393
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1848218 W Mark Sawicki C/O Cryoport Inc.
112 Westwood Place, Suite 350
Brentwood TN 37027
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-10 11,342 $3.07 30,342 No 4 M Direct
Common Stock Acquisiton 2021-03-10 7,231 $1.87 37,573 No 4 M Direct
Common Stock Acquisiton 2021-03-10 11,831 $3.21 49,404 No 4 M Direct
Common Stock Disposition 2021-03-10 3,974 $54.65 45,430 No 4 S Direct
Common Stock Disposition 2021-03-10 9,357 $55.33 36,073 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to purchase common stock Acquisiton 2021-03-09 21,333 $0.00 21,333 $58.94
Common Stock Restricted Stock Rights Acquisiton 2021-03-09 10,667 $0.00 10,667 $0.00
Common Stock Options to purchase common stock Disposition 2021-03-10 11,342 $0.00 11,342 $3.07
Common Stock Options to purchase common stock Disposition 2021-03-10 11,831 $0.00 11,831 $3.21
Common Stock Options to purchase common stock Disposition 2021-03-10 7,231 $0.00 7,231 $1.87
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
21,333 2028-03-09 No 4 A Direct
10,667 No 4 A Direct
0 2025-08-20 No 4 M Direct
0 2021-05-18 No 4 M Direct
0 2026-05-06 No 4 M Direct
Footnotes
  1. 1/48 of options vest on the 9th of each month for forty-eight months beginning 4/09/2021.
  2. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.
  3. The restricted stock rights vest in four equal annual installments beginning 3/9/2022.
  4. 1/48th of the 77,625 options originally granted vested on the 7th of each month for forty-eight months beginning June 7, 2015.
  5. 1/48th of the 78,000 options originally granted vested on the 18th of each month for forty-eight months beginning June 18, 2017.
  6. 1/48th of the 70,000 options originally granted vested on the 6th of each month for forty-eight months beginning June 6, 2016.